Printer Friendly

Pain Therapeutics Announces Inclusion in Russell 3000 Index.

Business Editors/Health & Medical Writers

SOUTH SAN FRANCISCO, Calif.--(BW HealthWire)--July 10, 2001

Pain Therapeutics, Inc. (Nasdaq:PTIE), a developer of next-generation opioid painkillers, today announced that its common stock has been added to the Russell 3000(R) Index, a leading investment ranking of U.S. stocks compiled by the Frank Russell Company.

The addition of Pain Therapeutics' stock was part of the annual reconstitution of the Russell Indexes. Membership in the Russell 3000(R) Index is determined by market capitalization rankings and style attributes, rather than by subjective opinion or committee decisions. The Russell Indexes are widely used by institutional investors as benchmarks for investment strategies.

"We are delighted to be added to this year's Russell 3000(R) Index," said Remi Barbier, president and chief executive officer of Pain Therapeutics. "This is a small but definitive step in our effort to raise PTI's visibility among institutional investors."

About Pain Therapeutics, Inc.

Pain Therapeutics, Inc. is an emerging leader in the area of pain management. The Company is developing a new generation of proprietary painkillers that addresses the deficiencies of morphine and other opioid painkillers that are widely used in clinical medicine. The Company is currently in Phase II clinical trials with multiple drug candidates. Pain Therapeutics is traded on Nasdaq under the symbol PTIE. For additional information, please visit the Company's website at
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 10, 2001
Previous Article:Deloitte & Touche Outsourcing & Interpath Collaborate On Complete Solution For Mid-Sized, Fast-Growth Companies.
Next Article:Vacation Like a Vanderbilt On Exclusive Fisher Island; ``The Perfect Summer Package'' Offers 20% Savings.

Related Articles
ARIAD Added to Russell Equity Indexes.
PolyMedica Added to the Russell 2000 & Russell 3000 Indices.
Curis Added to the Russell 2000 and 3000 Indexes.
VIVUS Joins Russell 3000 Index.
SciClone Selected for Russell 3000 Index.
Depomed to Be Added to Russell 2000 and 3000 Indexes.
Axonyx Inc. Added to Russell 3000 Index.
Emisphere Technologies, Inc. Scheduled to Join Russell 3000 Index; Company to Also be Added to Russell 2000 Index.
Alnylam Added to Russell 3000 and Russell 2000 Indexes.
Osiris Therapeutics Named to Russell Index.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters